Question Title

* 1. Participant Name:

Question Title

* 2. Why did you join the MAT Learning Collaborative? Why was it important for you to attend these sessions?

Question Title

* 3. What is one key takeaway for you at the conclusion of the Learning Collaborative Sessions?

Question Title

* 4. How will you apply the lessons learned from this series of Learning Collaborative sessions to your work?

Question Title

* 6. Please share any specific recommendations you may have for improving the sessions.

Question Title

* 7. Would you like to see additional Learning Collaborative sessions related to opioid use disorder based on the following topics?

  Yes No
Buprenorphine waiver training
Methadone and/or Vivitrol
MAT best practices in specific populations (pediatrics, pregnant women, veterans, geriatric, multi substance use)
Building linkages between primary care, EDs, and community-based providers

Question Title

* 8. If you would like to see other topics related to opioid use disorder that are not listed here, please specify:

Question Title

* 9. I would recommend this MAT Learning Collaborative series to other clinicians

Question Title

* 10. Please share your reason(s) for your response:

0 of 10 answered
 

T